(Q45148973)

10 December 2017

title

Possible involvement of toll-like receptors in the pathogenesis of myasthenia gravis (English)

1 reference

10 December 2017

0 references

0 references

Yu-Zhong Wang

1

1 reference

10 December 2017

Mei Yan

2

1 reference

10 December 2017

Fa-Fa Tian

3

1 reference

10 December 2017

Jun-Mei Zhang

4

1 reference

10 December 2017

Qun Liu

5

1 reference

10 December 2017

Huan Yang

6

1 reference

10 December 2017

Wen-Bin Zhou

7

1 reference

10 December 2017

Jing Li

8

1 reference

10 December 2017

language of work or name

1 reference

1 February 2013

1 reference

10 December 2017

1 reference

10 December 2017

volume

36

1 reference

10 December 2017

issue

1

1 reference

10 December 2017

page(s)

121-130

1 reference

Myasthenia gravis: past, present, and future

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Expression of TLR4 and TLR9 mRNA in Lewis rats with experimental allergic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Expression of Toll-like receptors 2, 4 and 9 in patients with Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Toll-like receptor family and signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Molecular mechanisms of immunomodulatory activity of glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid predendritic cells (pDCs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9526-6

Inactivation of TLR9 by a suppressive oligodeoxynucleotides can ameliorate the clinical signs of EAN

21 January 2018

1 reference

12 December 2020

Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and -4 by targeting TBK1 activation

1 reference

12 December 2020

1 reference

12 December 2020

Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients

1 reference

12 December 2020

Toll-like receptors: a family of innate sensors of danger that alert and drive immunity

1 reference

12 December 2020

Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA)

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S10753-012-9526-6

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

1039726255

0 references

1 reference